Product Information
FEXOFENADINE-PSE ER 60-120 TAB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.4832 per EA under NDC 43598082314. Its NADAC has been published 324 times since Jul 22, 2020.
FDA first approved this application on Nov 18, 2014.
Strength
60; 120 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598082314
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076667FDA Approved
11/18/2014
On Market Since
7/18/2019
Pharmacological Classes
Price Statistics
The NADAC for FEXOFENADINE-PSE ER 60-120 TAB has been published 324 times since Jul 22, 2020, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4832 per EA |
|---|---|
| All-time high | $0.6271 (Jan 13, 2021) |
| All-time low | $0.4115 (Nov 19, 2025) |
| 52-week high | $0.4832 |
| 52-week low | $0.4115 |
| Median price | $0.4768 |
| Average price | $0.4837 |
| Largest weekly change | +26.5% (May 19, 2021) |
| Weeks tracked | 324 |
| Tracking since | Jul 22, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fexofenadine HCl and Pseudoephedrine HCI market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEXOFENADINE-PSE ER 60-120 TAB?
The current National Average Drug Acquisition Cost (NADAC) for FEXOFENADINE-PSE ER 60-120 TAB, manufactured by Dr. Reddy's Laboratories Inc., is $0.4832 per EA (NDC 43598082314), effective Sep 30, 2026.
How has the price of FEXOFENADINE-PSE ER 60-120 TAB changed over time?
Over the history we have for it, the NADAC for FEXOFENADINE-PSE ER 60-120 TAB has declined 18.2%. It has been tracked across 324 weekly CMS publications since Jul 22, 2020.
What are the highest and lowest recorded NADAC prices for FEXOFENADINE-PSE ER 60-120 TAB?
Since Jul 22, 2020, the NADAC for FEXOFENADINE-PSE ER 60-120 TAB has ranged from a low of $0.4115 (Nov 19, 2025) to a high of $0.6271 (Jan 13, 2021), with a median of $0.4768 per EA.
Are there cheaper alternatives to FEXOFENADINE-PSE ER 60-120 TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FEXOFENADINE-PSE ER 60-120 TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FEXOFENADINE-PSE ER 60-120 TAB?
FEXOFENADINE-PSE ER 60-120 TAB (NDC 43598082314) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.